Zobrazeno 1 - 10
of 58
pro vyhledávání: '"Yuzo Hasegawa"'
Autor:
Nakamasa Hayashi, Hideaki Takahashi, Yuzo Hasegawa, Fumi Higuchi, Masamichi Takahashi, Keishi Makino, Masatoshi Takagaki, Jiro Akimoto, Takeshi Okuda, Yoshiko Okita, Koichi Mitsuya, Yasuyuki Hirashima, Yoshitaka Narita, Yoko Nakasu, On Behalf of the Committee of Brain Tumor Registry of Japan Supported by the Japan Neurosurgical Society
Publikováno v:
BMC Cancer, Vol 17, Iss 1, Pp 1-7 (2017)
Abstract Background The prevalence of brain metastases (BM) from uterine cancer has recently increased because of the improvement of overall survival (OS) of patients with uterine cancer due to its early detection and improved local control as a resu
Externí odkaz:
https://doaj.org/article/c01f979e4a9a43079c48d96a4d4358bd
Development of Treatment of Cancer-associated Venous Thromboembolism with Direct Oral Anticoagulants
Publikováno v:
The Japanese Journal of Phlebology. 31:45-51
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6a5e6cb01ca528fe15409e60359beb82
https://doi.org/10.7134/phlebol.19-28
https://doi.org/10.7134/phlebol.19-28
Publikováno v:
Neurological Sciences. 41:1245-1250
The commonest type of ischemic cerebral stroke in patients with cancer is cryptogenic stroke (CRS), the majority of which are considered cancer-associated strokes (CAS) caused by multiple microemboli associated with hypercoagulation, known as Trousse
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e66a1d973082bafbfba6e06fb7c7ddde
https://doi.org/10.1007/s10072-019-04231-5
https://doi.org/10.1007/s10072-019-04231-5
Publikováno v:
Neuro-Oncology Advances. 4:iii22-iii22
Background Leptomeningeal carcinomatosis (LMC) is the most difficult condition to treat brain metastases (BM), and the presence or absence of malignant cells in the cerebrospinal fluid (CSF) is important in determining treatment strategies. Here, we
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f43369039aa401acda99f7981e9df507
https://doi.org/10.1093/noajnl/vdac167.086
https://doi.org/10.1093/noajnl/vdac167.086
Autor:
Toshihiko Iuchi, Masato Syngyoji, Hironori Ashinuma, Satoko Mizuno, Yuzo Hasegawa, Taiki Setoguchi, Junji Hosono, Tsukasa Sakaida
Publikováno v:
Neuro-oncology Advances
Background: Because of the invasive nature of small cell lung cancer (SCLC), the effectiveness of local therapy for brain metastases (BM) from SCLC had been limited. In this article, we retrospectively evaluated the efficacy of chemotherapy against n
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::41cb6b34722533bf5551074e5117ba17
http://europepmc.org/articles/PMC8664637
http://europepmc.org/articles/PMC8664637
Publikováno v:
Internal Medicine
The mechanisms underlying anaplastic lymphoma kinase (ALK) resistance have not been well investigated in clinical practice. We herein report the case of a lung cancer patient with carcinomatous meningitis who had an ALK I1171T resistance mutation rev
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::02c7ecc4c83755031ae65cf4f8872d91
https://doi.org/10.2169/internalmedicine.0397-17
https://doi.org/10.2169/internalmedicine.0397-17
Publikováno v:
Scientific Reports
Scientific Reports, Vol 9, Iss 1, Pp 1-9 (2019)
Scientific Reports, Vol 9, Iss 1, Pp 1-9 (2019)
In the management of patients with newly diagnosed glioblastoma, there is no standard duration for adjuvant temozolomide treatment. This study aimed to assess the feasibility of finalizing adjuvant temozolomide treatment on the basis of methionine up
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1e398279617a3f1b772df23f0d713870
https://doi.org/10.1038/s41598-019-54398-2
https://doi.org/10.1038/s41598-019-54398-2
Publikováno v:
Journal of Clinical Neuroscience. 31:67-71
The development of perifocal edema and tumor bed cyst has been reported after implantation of biodegradable carmustine wafers for the treatment of malignant gliomas. We retrospectively evaluated these changes in a series of patients; 19 consecutive p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ebd1ea6d2e0dd6ca1f497af0af5db1d7
https://doi.org/10.1016/j.jocn.2015.12.033
https://doi.org/10.1016/j.jocn.2015.12.033
Autor:
T. Sakaida, Toshihiko Iuchi, Hironori Ashinuma, Yasushi Yoshida, Yuzo Hasegawa, Masato Shingoji, Satoko Mizuno, T. Setoguchi
BACKGROUND: Despite the favorable response, most brain metastases (MBs) acquire resistance to TKIs. T790M is the most common mechanism and accounts for approximately half of acquired resistance to TKIs. The aim of this study is to clarify the role of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::75e6c9cef3f47666a66c5e382fe22219
https://europepmc.org/articles/PMC6216946/
https://europepmc.org/articles/PMC6216946/
Autor:
Toshihiko Iuchi, Junji Hosono, Gentaro Togasaki, Takahiro Sugiyama, Ryusuke Hara, T. Sakaida, T. Setoguchi, Yuzo Hasegawa, Akio Higuchi, Makiko Itami, Hajime Kageyama
Publikováno v:
Neuro-oncology Advances
PURPOSE/OBJECTIVE The molecular responses of glioblastomas (GBMs) to hypofractionated IMRT/TMZ were investigated to elucidate the molecular targets included in the resistance of these tumors to chemo-radiation therapy. MATERIALS /METHODS Phase I stud
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fd0ca56c109b490a5d385649be68891a
https://doi.org/10.1093/noajnl/vdz039.033
https://doi.org/10.1093/noajnl/vdz039.033